Select Medical (NYSE:SEM) Rating Lowered to Hold at StockNews.com

Select Medical (NYSE:SEM - Get Free Report) was downgraded by investment analysts at StockNews.com from a "buy" rating to a "hold" rating in a research report issued to clients and investors on Thursday.

Several other brokerages also recently commented on SEM. Royal Bank of Canada lifted their target price on Select Medical from $40.00 to $47.00 and gave the stock an "outperform" rating in a report on Monday, November 4th. Benchmark reaffirmed a "buy" rating and set a $48.00 target price on shares of Select Medical in a report on Friday, November 1st. Finally, Bank of America began coverage on Select Medical in a report on Tuesday, August 20th. They set a "buy" rating and a $42.00 target price on the stock. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, Select Medical has an average rating of "Moderate Buy" and a consensus target price of $40.75.

Select Medical Trading Up 2.9 %

NYSE SEM opened at $38.09 on Thursday. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. Select Medical has a twelve month low of $22.26 and a twelve month high of $40.98. The company has a market cap of $4.93 billion, a price-to-earnings ratio of 17.80, a price-to-earnings-growth ratio of 1.95 and a beta of 1.42. The business's fifty day moving average is $34.93 and its 200 day moving average is $34.92.

Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. During the same quarter last year, the business posted $0.46 EPS. Select Medical's revenue for the quarter was up 5.7% on a year-over-year basis. As a group, sell-side analysts expect that Select Medical will post 2.16 EPS for the current fiscal year.

Institutional Trading of Select Medical

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Tidal Investments LLC bought a new stake in Select Medical in the 1st quarter valued at about $467,000. UniSuper Management Pty Ltd bought a new stake in Select Medical during the 1st quarter worth approximately $730,000. Hood River Capital Management LLC bought a new stake in Select Medical during the 2nd quarter worth approximately $14,819,000. Comerica Bank increased its holdings in Select Medical by 30.0% during the 1st quarter. Comerica Bank now owns 68,485 shares of the health services provider's stock worth $2,065,000 after purchasing an additional 15,824 shares in the last quarter. Finally, Boston Partners bought a new stake in Select Medical during the 1st quarter worth approximately $718,000. 89.48% of the stock is owned by institutional investors.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.